Healthy men help scientists track mystery Drug's journey through the body
NCT ID NCT05833035
First seen Jan 29, 2026
Summary
This completed Phase 1 trial studied how the experimental drug BI 1291583 is broken down and removed from the body. Eight healthy men took a single oral dose containing a tiny radioactive marker. Researchers measured the drug and its breakdown products in blood, urine, and stool over several weeks to understand how the body handles it. This study does not test any treatment effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON
Groningen, 9728 NZ, Netherlands
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BI 1291583 (with radioactive carbon tracer)
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.